𝔖 Bobbio Scriptorium
✦   LIBER   ✦

8 High-dose megestrol acetate in advanced ovarian cancer: A phase II study

✍ Scribed by C.H.N. Veenhof; M.E.L. van der Burg; F. Carnino; M. Forni; C.F. de Oliveira; N. Rotmensz; J.B. Vermorken

Book ID
116007009
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
100 KB
Volume
28
Category
Article
ISSN
0022-4731

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of high-dose medroxypro
A phase II study of high-dose medroxyprogesterone acetate in advanced breast cancer
✍ Geoffrey Falkson; HΓ¨ndrΓ© C. Falkson πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 215 KB

Twenty-three evaluable patients with advanced breast cancer were treated with MPA, 1,400 mg/m2 daily PO for the first 6 months, and 500 mg/m2 daily PO thereafter. The median total dose was 191,400 mg in 88 days, with the maximum dose given to date 522,600 mg in 282 days. Most patients tolerated high